Condensed Consolidated Statements of Net Loss (Unaudited) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue		$ 350,207	$ 182,784	$ 630,524	$ 477,727
Cost of goods sold		142,877	85,261	240,635	177,918
Gross profit		207,330	97,523	389,889	299,809
General and administrative expense		2,077,973	3,211,817	5,348,750	6,040,293
Operations expense		567,796	521,116	1,142,608	1,069,869
Sales and marketing expense		159,788	133,015	274,429	397,424
Total operating loss		(2,598,227)	(3,768,425)	(6,375,898)	(7,207,777)
Other income		57,033	52,965	85,292	52,968
Other expense		(1,829)	(729,837)	(236,801)	(1,846,912)
Gain (loss) on derivative instruments		(30,909)	(422,081)	64,762	(394,974)
Gain on notes receivables associated with asset purchase		0	1,290,000	0	1,290,000
Net loss		(2,573,932)	(3,577,378)	(6,462,645)	(8,106,695)
Net loss attributable to common shareholders per common shares-basic and diluted		$ (2,573,932)	$ (3,577,378)	$ (6,462,645)	$ (8,106,695)
Loss per common share basic (in dollars per share)		$ (0.05)	$ (0.36)	$ (0.15)	$ (1.10)
Loss per common share diluted (in dollars per share)		$ (0.05)	$ (0.36)	$ (0.15)	$ (1.10)
Weighted average shared used in computation - basic (in shares)	[1]	51,581,762	9,838,152	44,089,157	7,362,240
Weighted average shared used in computation - diluted (in shares)		51,581,762	9,838,152	44,089,157	7,362,240

[1] The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive: